Back to Search
Start Over
The microbial coinfection in COVID-19.
- Source :
-
Applied microbiology and biotechnology [Appl Microbiol Biotechnol] 2020 Sep; Vol. 104 (18), pp. 7777-7785. Date of Electronic Publication: 2020 Aug 11. - Publication Year :
- 2020
-
Abstract
- The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel β-coronavirus, is the main pathogenic agent of the rapidly spreading pneumonia called coronavirus disease 2019 (COVID-19). SARS-CoV-2 infects much more people, especially the elder population, around the world than other coronavirus, such as SARS-CoV and MERS-CoV, which is challenging current global public health system. Beyond the pathogenesis of SARS-CoV-2, microbial coinfection plays an important role in the occurrence and development of SARS-CoV-2 infection by raising the difficulties of diagnosis, treatment, prognosis of COVID-19, and even increasing the disease symptom and mortality. We summarize the coinfection of virus, bacteria and fungi with SARS-CoV-2, their effects on COVID-19, the reasons of coinfection, and the diagnosis to emphasize the importance of microbial coinfection in COVID-19. KEY POINTS: • Microbial coinfection is a nonnegligible factor in COVID-19. • Microbial coinfection exacerbates the processes of the occurrence, development and prognosis of COVID-19, and the difficulties of clinical diagnosis and treatment. • Different virus, bacteria, and fungi contributed to the coinfection with SARS-CoV-2.
- Subjects :
- Anti-Bacterial Agents therapeutic use
Antiviral Agents therapeutic use
Bacterial Infections drug therapy
Bacterial Infections microbiology
Bacterial Infections virology
Betacoronavirus drug effects
Betacoronavirus immunology
Betacoronavirus pathogenicity
COVID-19
Coinfection
Coronavirus Infections drug therapy
Coronavirus Infections microbiology
Coronavirus Infections virology
Cytokine Release Syndrome drug therapy
Cytokine Release Syndrome microbiology
Cytokine Release Syndrome virology
Cytokines biosynthesis
Disease Progression
Host-Pathogen Interactions immunology
Humans
Immunity, Innate drug effects
Lymphocytes microbiology
Lymphocytes virology
Lymphopenia drug therapy
Lymphopenia microbiology
Lymphopenia virology
Mycoses drug therapy
Mycoses microbiology
Mycoses virology
Pneumonia, Viral drug therapy
Pneumonia, Viral microbiology
Pneumonia, Viral virology
SARS-CoV-2
Virus Diseases drug therapy
Virus Diseases microbiology
Virus Diseases virology
Bacterial Infections epidemiology
Coronavirus Infections epidemiology
Cytokine Release Syndrome epidemiology
Lymphopenia epidemiology
Mycoses epidemiology
Pandemics
Pneumonia, Viral epidemiology
Virus Diseases epidemiology
Subjects
Details
- Language :
- English
- ISSN :
- 1432-0614
- Volume :
- 104
- Issue :
- 18
- Database :
- MEDLINE
- Journal :
- Applied microbiology and biotechnology
- Publication Type :
- Academic Journal
- Accession number :
- 32780290
- Full Text :
- https://doi.org/10.1007/s00253-020-10814-6